The canagliflozin and renal endpoints in diabetes with established nephropathy clinical evaluation (CREDENCE) study rationale, design, and baseline characteristics

Jardine Meg J., Mahaffey Kenneth W., Neal Bruce, Agarwal Rajiv, Bakris George L., Brenner Barry M., Kollaborációs szervezet: CREDENCE study investigators, Csecsei Gyöngyi, Csiky Botond, Danos Péter, Deák László, Dudás Mihály, Keltai Katalin, Takács Róbert, Rosivall László, et al
2017

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From th...

Mahaffey Kenneth W., Jardine Meg J., Bompoint Severine, Cannon Christopher P., Neal Bruce, Heerspink Hiddo J.L, Charytan David M., Edwards Robert, Agarwal Rajiv, Bakris George, Bull Scott, Kollaborációs szervezet: REDENCE Study Investigators, Keltai Katalin, Takács Róbert, et al
2019